People in the News


Akonni Biosystems has appointed Jan Smilek as chief financial officer, the company said this week.

Smilek most recently served as CFO and treasurer of Sucampo Pharmaceuticals, where he co-led the $80 million acquisition of Sucampo AG in December 2010. He has also served as senior director of finance for Vanda Pharmaceuticals; and as a senior manager for PricewaterhouseCoopers. Smilek holds a BA in economics from the School of Economics in Bratislava, Czech Republic; and an MBA from Georgetown University's McDonough School of Business.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

Researchers find that a personalized medicine approach could help people who experience pain while taking statins, New Scientist reports.

US National Science Foundation is continuing its responsible research conduct training policy despite its flaws, ScienceInsider reports.

A CRISPR-themed meeting explored how the tool could and should be used, Wired reports.

In Science this week: database of proteins' effects on cancer, targeted error correction sequencing, and more.